Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Jerash Holdings (US) (JRSH) EBT (2016 - 2025)

Jerash Holdings (US) (JRSH) has disclosed EBT for 10 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 239.81% year-over-year to $1.5 million, compared with a TTM value of $1.7 million through Dec 2025, up 143.2%, and an annual FY2025 reading of -$1.1 million, up 50.91% over the prior year.
  • EBT was $1.5 million for Q4 2025 at Jerash Holdings (US), up from $599506.0 in the prior quarter.
  • Across five years, EBT topped out at $5.5 million in Q3 2021 and bottomed at -$4.0 million in Q1 2024.
  • Average EBT over 5 years is $757541.2, with a median of $745855.0 recorded in 2023.
  • The sharpest move saw EBT soared 1928.63% in 2021, then plummeted 799.71% in 2023.
  • Year by year, EBT stood at $2.3 million in 2021, then plummeted by 47.73% to $1.2 million in 2022, then crashed by 77.72% to $270705.0 in 2023, then skyrocketed by 68.46% to $456028.0 in 2024, then soared by 239.81% to $1.5 million in 2025.
  • Business Quant data shows EBT for JRSH at $1.5 million in Q4 2025, $599506.0 in Q3 2025, and $606748.0 in Q2 2025.